Afrezza News Today

>> we are going to show [bleep] the power of the [bleep] south bronx. we are going to show them whos the [bleep] we are. get big money out of politics. i am the hip-hop congressman! >> sandra: jamaal bowman new york congressman rallying the progressive allies of the bronx to heaven over the weekend as new york voters head to the ballot box for todays primary. the race for the 16th congressional district will be one of the most closely watched as bowman faces a tough challenge from mode...

It's common knowledge that diabetics receive their insulin through injections or pumps. However, many people don't know of a new option. Inhalable insulin is available to adults, and a local study could soon make it available to kids.

MannKind Pharmaceuticals has shipped an initial batch of an inhaled treatment for...

Long based outside Los Angeles, MannKind has adopted Danbury as its new headquarters,...

Long based outside Los Angeles, MannKind has adopted Danbury as its new headquarters,...

A drugmaker has struck a $100 million deal to sell and lease back its 260,000-square-foot...

MannKind Corp. touted increased sales for its flagship drug Afrezza during its fourth quarter earnings report on Thursday, while pointing out its new direction toward therapies for lung and endocrine diseases. During the quarter, MannKind pulled in $10.1 million in revenue for Afrezza, its inhalable insulin, a 30 percent increase compared to sales in the same quarter of 2019. The Westlake Village biotech company reported an adjusted net loss of $13.2 million (-6 cents a share). That’s narrowe...

Latest updates on this topic.